Observational constraints on the neutron star mass distribution

Radio observations of neutron star binary pulsar systems have constrained strongly the masses of eight neutron stars. Assuming neutron star masses are uniformly distributed between lower and upper bounds $m_l$ and $m_u$, the observations determine with 95\% confidence that $1.01 < m_l/\text{M}_\odot < 1.34$ and $1.43 < m_u/\text{M}_\odot < 1.64$. These limits give observational support to neutron star formation scenarios that suggest that masses should fall predominantly in the range $1.3<m/\text{M}_\odot<1.6$, and will also be important in the interpretation of binary inspiral observations by the Laser Interferometer Gravitational-wave Observatory.Comment: Postscript, 4 pages, NU-GR-

Ground-state properties of the Rokhsar-Kivelson dimer model on the triangular lattice

We explicitly show that the Rokhsar-Kivelson dimer model on the triangular lattice is a liquid with topological order. Using the Pfaffian technique, we prove that the difference in local properties between the two topologically degenerate ground states on the cylinders and on the tori decreases exponentially with the system size. We compute the relevant correlation length and show that it equals the correlation length of the vison operator.Comment: 10 pages, 9 figure

Resummation of the hadronic tau decay width with the modified Borel transform method

A modified Borel transform of the Adler function is used to resum the hadronic tau decay width ratio. In contrast to the ordinary Borel transform, the integrand of the Borel integral is renormalization--scale invariant. We use an ansatz which explicitly accounts for the structure of the leading infrared renormalon. Further, we use judiciously chosen conformal transformations for the Borel variable, in order to map sufficiently away from the origin the other ultraviolet and infrared renormalon singularities. In addition, we apply Pade approximants for the corresponding truncated perturbation series of the modified Borel transform, in order to further accelerate the convergence. Comparing the results with the presently available experimental data on the tau hadronic decay width ratio, we obtain $\alpha_s(M^z) = 0.1192 +- 0.0007_{exp.} +- 0.0010_{EW+CKM} +- 0.0009_{th.} +- 0.0003_{evol.}$. These predictions virtually agree with those of our previous resummations where we used ordinary Borel transforms instead.Comment: 32 pages, 2 eps-figures, revtex; minor changes in the formulations; a typo in Eq.(47) corrected; version as appearing in Phys. Rev.

Measurement of the B0-anti-B0-Oscillation Frequency with Inclusive Dilepton Events

The $B^0$-$\bar B^0$ oscillation frequency has been measured with a sample of 23 million \B\bar B pairs collected with the BABAR detector at the PEP-II asymmetric B Factory at SLAC. In this sample, we select events in which both B mesons decay semileptonically and use the charge of the leptons to identify the flavor of each B meson. A simultaneous fit to the decay time difference distributions for opposite- and same-sign dilepton events gives $\Delta m_d = 0.493 \pm 0.012{(stat)}\pm 0.009{(syst)}$ ps$^{-1}$.Comment: 7 pages, 1 figure, submitted to Physical Review Letter

Study of \Omega_c^0 and \Omega_c^{*0} Baryons at Belle

We report results from a study of the charmed double strange baryons \Omega_c^0 and \Omega_c^{*0} at Belle. The \Omega_c^0 is reconstructed using the \Omega_c^0 --> \Omega^- \pi^+ decay mode, and its mass is measured to be (2693.6 \pm 0.3 {+1.8 \atop -1.5}) MeV/c^2. The \Omega_c^{*0} baryon is reconstructed in the \Omega_c^0 \gamma mode. The mass difference M_{\Omega_c^{*0}} - M_{\Omega_c^0} is measured to be (70.7 \pm 0.9 {+0.1 \atop -0.9}) MeV/c^2. The analysis is performed using 673 fb^{-1} of data on and near the \Upsilon(4S) collected with the Belle detector at the KEKB asymmetric-energy e^+e^- collider.Comment: 11 pages, 5 figures, prepared for 34th International Conference on High Energy Physics (ICHEP 08), Philadelphia, PA, 29 Jul - 5 Aug 200

The Public Repository of Xenografts enables discovery and randomized phase II-like trials in mice

More than 90% of drugs with preclinical activity fail in human trials, largely due to insufficient efficacy. We hypothesized that adequately powered trials of patient-derived xenografts (PDX) in mice could efficiently define therapeutic activity across heterogeneous tumors. To address this hypothesis, we established a large, publicly available repository of well-characterized leukemia and lymphoma PDXs that undergo orthotopic engraftment, called the Public Repository of Xenografts (PRoXe). PRoXe includes all de-identified information relevant to the primary specimens and the PDXs derived from them. Using this repository, we demonstrate that large studies of acute leukemia PDXs that mimic human randomized clinical trials can characterize drug efficacy and generate transcriptional, functional, and proteomic biomarkers in both treatment-naive and relapsed/refractory disease